FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.
|Articles|April 14, 2020
Telepsychiatry Comes of Age, Reluctantly
Author(s)Chris Aiken, MD
Practical tips to help clinicians get started or to hone skills in telepsychiatry.
Advertisement
Chris Aiken, MD, provides practical tips to help clinicians get started or to hone their skills in telepsychiatry.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
2
FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
3
Clozapine Remains Underused After REMS Elimination: A Conversation With Jose Rubio, MD, PhD
4
Phase 1 Clinical Studies Completed: NTX-253 for the Treatment of Schizophrenia
5